CALGARY, Alberta, Aug. 05, 2026 (GLOBE NEWSWIRE) — Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug discovery company developing novel therapeutics for autism spectrum disorder and related conditions, is pleased to announce positive results from its preclinical Fragile X study conducted…
Nights full of panic and nightmares: people with post-traumatic stress disorder often suffer from extreme sleep disorders. There is no medication specifically for this - at least until now.
The DR Congo is set to open its largest Ebola treatment facility. Construction is nearing completion as health authorities race to contain an outbreak that the World Health Organization has described…
The experiment found that a modified analogue of vitamin B12 known as nitrosylcobalamin (NO-Cbl) that was specifically designed to include nitric oxide, a substance that can kill tumour cells…
